Search - tctmd.com

Displaying 81 - 100 of 644

Sort: Relevancy | Date

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Caitlin E. Cox

September 01, 2025

News Daily News

What’s the Damage With Long COVID? Advanced Imaging Reveals Clues

Caitlin E. Cox

May 27, 2025

Presentation Fellows 2025

Pulmonary Embolism and Venous Disease: The Hottest Frontier of Endovascular Intervention

Presenter: S. Jay Mathews

May 18, 2025

Presentation Fellows 2025

Lightning Flash 2.0 Technology Overview and Case Presentations

Presenter: Sonal Pruthi

May 18, 2025

Presentation Fellows 2025

CATRX Product Overview and Case Presentations

Presenter: Sahil A. Parikh

May 18, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Daily News

CV Death Rates in Autoimmune Disorders Waning, but Still Higher in Women

L.A. McKeown

May 14, 2025

News Conference News HRS 2025

Studies Spotlight Safety Concerns With Pulsed-Field Ablation for AF

Todd Neale

May 05, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

Presentation THT 2025

Acute PE Risk Stratification: Where Do Hemodynamics Fit In?

Presenter: Eric Secemsky

February 12, 2025

Presentation THT 2025

Clinical Trial Updates: What's New? What's Coming?

Presenter: Jay Giri

February 12, 2025

Presentation THT 2025

Medical Management (Heparin/ Lytics)

Presenter: Gregory Piazza

February 12, 2025

Presentation THT 2025

Invasive Therapies (Inari/EKOS)

Presenter: Sareena George

February 12, 2025

Presentation THT 2025

Thrombectomy: Case in a Box

Presenter: Sanjum Sethi

February 12, 2025

Presentation THT 2025

Case Presentation: Submassive PE With Normotensive Shock

Presenter: Maya Serhal

February 12, 2025

Presentation THT 2025

Case Resolution and Discussion

Presenter: Maya Serhal

February 12, 2025

Presentation THT 2025

Role of MCS in PE Management

Presenter: Karthikeyan Ranganathan

February 12, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

Caitlin E. Cox

December 27, 2024

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

L.A. McKeown

December 03, 2024

Advertisement

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

What’s the Damage With Long COVID? Advanced Imaging Reveals Clues

Pulmonary Embolism and Venous Disease: The Hottest Frontier of Endovascular Intervention

Lightning Flash 2.0 Technology Overview and Case Presentations

CATRX Product Overview and Case Presentations

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

CV Death Rates in Autoimmune Disorders Waning, but Still Higher in Women

Studies Spotlight Safety Concerns With Pulsed-Field Ablation for AF

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Acute PE Risk Stratification: Where Do Hemodynamics Fit In?

Clinical Trial Updates: What's New? What's Coming?

Medical Management (Heparin/ Lytics)

Invasive Therapies (Inari/EKOS)

Thrombectomy: Case in a Box

Case Presentation: Submassive PE With Normotensive Shock

Case Resolution and Discussion

Role of MCS in PE Management

Top Endovascular News of 2024

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content